93 programming-"https:"-"Inserm"-"FEMTO-ST" "https:" "https:" "https:" "https:" "https:" research jobs at University of Washington
Sort by
Refine Your Search
-
interdisciplinary research program. Our lab investigates how bacteria and human mitochondria maintain homeostasis and respond to stress and environmental challenges. A central focus of our research is uncovering
-
statistical and database management programs to analyze data and prepare summary narrative reports, graphs, tables, charts and illustrations. Assist with preparation of presentation and manuscripts
-
through various educational and outreach efforts. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu
-
U-Pass for eligible employees. WashU provides eligible employees with a defined contribution (403(b)) Retirement Savings Plan, which combines employee contributions and university contributions
-
appointments and lower copays/coinsurance. Take advantage of our free Metro transit U-Pass for eligible employees. WashU provides eligible employees with a defined contribution (403(b)) Retirement Savings Plan
-
eligible employees with a defined contribution (403(b)) Retirement Savings Plan, which combines employee contributions and university contributions starting at 7%. Wellness Wellness challenges, annual health
-
provides eligible employees with a defined contribution (403(b)) Retirement Savings Plan, which combines employee contributions and university contributions starting at 7%. Wellness Wellness challenges
-
appointments and lower copays/coinsurance. Take advantage of our free Metro transit U-Pass for eligible employees. WashU provides eligible employees with a defined contribution (403(b)) Retirement Savings Plan
-
employees. WashU provides eligible employees with a defined contribution (403(b)) Retirement Savings Plan, which combines employee contributions and university contributions starting at 7%. Wellness Wellness
-
role in immune modulation. In addition, the lab also has a robust program in development of small molecule inhibitors as therapeutic option for these cancers. The lab has previously identified multiple